Researchers at Duke University have developed a jelly-based delivery method to help delay the process of peptide drug breakdown in diabetes patients. The method uses an injectable fusion protein that fuses peptide drug copies with heat-sensitive polymers. The protein, which is less painful and easier to inject than microsphere-release technology, turns into jelly inside the body and is slowly broken down by enzymes to release the peptides.

Full Story:
Wired.co.uk (U.K.)

Related Summaries